Emapalumab
| Emapalumab | |
|---|---|
| Term | Emapalumab |
| Short definition | emapalumab (EH-muh-PAL-yoo-mab) A drug used to treat a rare immune system disorder called primary hemophagocytic lymphohistiocytosis (HLH). It is used in patients whose disease has come back, gotten worse, has not improved, or cannot be treated with other therapy. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
emapalumab - (pronounced) (EH-muh-PAL-yoo-mab) A drug used to treat a rare immune system disorder called primary hemophagocytic lymphohistiocytosis (HLH). It is used in patients whose disease has come back, gotten worse, has not improved, or cannot be treated with other therapy. It is also being studied in the treatment of other conditions. Emapalumab binds to an immune system protein called interferon gamma, which is found at higher than normal levels in people with HLH. This can help lower the body's immune response and reduce inflammation. Emapalumab is a type of monoclonal antibody. Also called gamifant
External links
- Medical encyclopedia article on Emapalumab
- Wikipedia's article - Emapalumab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski